Background: Clinical diabetic traits have been reported to be associated with increased colorectal cancer (CRC) risk in observational studies. Using the Mendelian randomization (MR) analysis method, we examined the causal association between glycemic traits, such as fasting glucose (FG), fasting insulin (FI), and glycosylated hemoglobin A1c (HbA1c), and survival in a cohort of CRC patients.Methods: We conducted a two‐sample MR analysis among a cohort of patients with locally advanced CRC at Seoul National University Hospital. Single‐nucleotide polymorphisms robustly associated (p < 5 × 10−8) with the three glycemic traits were obtained from the Meta‐Analyses of Glucose and Insulin‐related traits Consortium, Asian Genetic Epidemiology Network, and Korea Biobank Array. Three‐year and 5‐year overall survival (OS) and progression‐free survival (PFS) were used as outcomes. Survival analysis was conducted using subgroup analysis by cancer stage and subsite in a multivariate Cox proportional hazards model adjusted for age and sex to examine whether glycemic traits affected survival.Results: A total of 509 patients were included in our final analysis. MR analysis showed that HbA1c levels were associated with poor 3‐year OS (β = 4.20, p = 0.02). Sensitivity analyses did not show evidence of any violations of the MR assumptions. In the cancer subgroup analysis of the Cox proportional hazards model, pooled hazard ratios for FG were significantly associated with poor 3‐year OS and PFS regardless of cancer stage. FI was not significantly associated with any 3‐year survival endpoints. Among Stage III patients, three glycemic traits were significantly associated with both 5‐year OS and PFS. Location‐specific subgroup analysis showed a significant association between three glycemic traits and 5‐year PFS in patients with left‐sided colon cancer. FG was associated with poor 3‐year survival for colon cancer but not rectal cancer.Conclusions: Our results suggest that FG and HbA1c could be used to predict prognosis in CRC patients. Lifestyle and/or pharmacological interventions targeting glycemic traits could help improve survival for CRC patients.
Idiopathic ventricular fibrillation (IVF) and early repolarization syndrome (ERS) are rare but potentially life-threatening arrhythmias. Their clinical distinction is often challenging and prognostic factors remain unclear, particularly in adolescents. This study compared clinical outcomes and electrocardiographic (ECG) characteristics of adolescents with IVF and ERS to identify disease-specific prognostic factors. Patients diagnosed as having IVF or ERS between 2000 and 2022 were retrospectively reviewed from a nationwide Korean multicenter cohort of pediatric inherited arrhythmia syndromes. ECGs were systematically reanalyzed for early repolarization patterns (ERPs). Life-threatening arrhythmic events (LAEs), including ventricular arrhythmias, appropriate implantable cardioverter-defibrillator shock, and sudden cardiac arrest, were compared between the groups. ECG reanalysis led to the reclassification of 10 patients from IVF to ERS, resulting in 14 patients with ERS and 25 patients with IVF (mean age 16.0 ± 2.3; 92.3% male). LAEs were more frequent in the ERS group (92.9% vs 52.0%; P = .025), with shorter LAE-free survival (median 7.2 vs 51.6 months; P = .005). In ERS, inferolateral ERP predicted poorer prognosis than inferior ERP (hazard ratio 9.29 [1.68–101.36]; P = .009), whereas coexistence of supraventricular tachycardia was a risk factor for LAEs in IVF (hazard ratio 7.24 [1.89–29.73]; P = .005). J-wave duration was longer in inferolateral ERP and in cases with pause-dependent augmentation. IVF and ERS have distinct prognoses and risk factors in adolescent patients. ECG-based differentiation and identification of prognostic factors may guide individualized strategies.